This is to inform you that the Board of Directors at its meeting held today i.e. 30th May, 2025, has, inter alia approved the Audited Standalone Financial Results of the Company for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 2.0 pts less than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Citichem India Ltd's Board of Directors, at their meeting on 30 May 2025, approved the Audited Standalone Financial Results for the financial year ended 31 March 2025. The auditor (NGST & Associates) issued an unmodified opinion, confirming the financial statements give a true and fair view. Total revenue grew to approximately ₹35.68 crore from ₹31.51 crore in the previous year, a growth of about 13%. Profit before tax rose to roughly ₹11.35 crore compared to ₹7.29 crore in FY24, showing a strong improvement of around 56%. The company operates in a single segment (Chemicals) and is listed on the BSE SME platform, hence exempted from mandatory IND-AS adoption.
A clean audit opinion combined with solid revenue and profit growth year-on-year is a positive sign for shareholders, indicating healthy operational performance. The improved profitability could support better investor sentiment, though the stock remains on the BSE SME platform with limited liquidity.